Shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report) were down 5.3% on Tuesday . The stock traded as low as $72.68 and last traded at $71.05. Approximately 224,192 shares changed hands during mid-day trading, a decline of 83% from the average daily volume of 1,300,976 shares. The stock had previously closed at $75.01.
Direxion Daily S&P Biotech Bull 3x Shares Trading Down 5.4 %
The business’s fifty day simple moving average is $88.92 and its 200 day simple moving average is $110.69.
Institutional Trading of Direxion Daily S&P Biotech Bull 3x Shares
Several institutional investors and hedge funds have recently made changes to their positions in the business. Dunhill Financial LLC bought a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter worth approximately $46,000. Spire Wealth Management bought a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the fourth quarter valued at about $68,000. SBI Securities Co. Ltd. bought a new position in Direxion Daily S&P Biotech Bull 3x Shares during the fourth quarter worth about $244,000. B. Riley Wealth Advisors Inc. bought a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter valued at about $279,000. Finally, SG Americas Securities LLC grew its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 6.0% during the 4th quarter. SG Americas Securities LLC now owns 3,392 shares of the company’s stock worth $305,000 after purchasing an additional 193 shares in the last quarter.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Further Reading
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- Stock Market Upgrades: What Are They?
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
- There Are Different Types of Stock To Invest In
- Joby Aviation: From Prototype to Profitability
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.